180 Life Sciences Corp Financial Flexibility Index
180 Life Sciences Corp financial flexibility index. 180 Life Sciences Corp (ATNF) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-16.30 Million (operating CF $-16.30 Million minus capex $3.00) represents 0% of total liabilities ($564.18 Million). See ATNF cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of 180 Life Sciences Corp (2017–2024)
Financial flexibility index of 180 Life Sciences Corp from 2017 to 2024. Historical Financial Flexibility Index trend for 180 Life Sciences Corp across 8 annual periods. Check how high is 180 Life Sciences Corp's earnings quality to evaluate the quality of earnings relative to operating cash generation.
180 Life Sciences Corp Financial Flexibility Index by Year (2017–2024)
180 Life Sciences Corp financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for 180 Life Sciences Corp. For the full cash flow conversion analysis, see 180 Life Sciences Corp cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $-3.87 Million | $25.25 Million | ▲ +35.7% |
| 2019 | -0.24x | $-3.17 Million | $-3.32 Million | $13.31 Million | ▼ -187.2% |
| 2018 | -0.08x | $-758.40K | $-789.23K | $9.14 Million | ▲ +29.3% |
| 2017 | -0.12x | $-497.36K | $-497.36K | $4.23 Million | — |